Navigation Links
Biopure Announces 2008 Second Quarter Financial Results
Date:5/21/2008

CAMBRIDGE, Mass., May 21 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) today announced its financial results for the second fiscal quarter ended April 30, 2008. For the quarter, the company reported a net loss of $5.0 million, or $0.14 per common share, compared with a net loss of $6.2 million, or $0.40 per common share, for the corresponding period in 2007. Class A common shares outstanding on April 30, 2008 and 2007 were 34,971,087 and 15,591,025, respectively.

Revenues

Total revenues for the second fiscal quarter of 2008 were $902,000, including $777,000 from sales of the company's veterinary product Oxyglobin(R), $89,000 from sales of Hemopure(R) in South Africa and $36,000 in research and development expense reimbursements from the U.S. government. Total revenues for the same period in fiscal 2007 were $619,000, including $500,000 from Oxyglobin sales, $6,000 from sales of Hemopure and $113,000 from government reimbursement. Payments from the government reimburse Biopure for trauma development expenses for Hemopure and vary with the amount of reimbursable activity for the government.

Hemopure sales increased during the second fiscal quarter of 2008 due to the increasing use of the product in South Africa. Oxyglobin revenues increased during the second fiscal quarter of 2008 compared to the same period in 2007 primarily due to higher unit sales to the company's European distributor. During the second fiscal quarter of 2007, the company accounted for European sales on a consignment basis. Now the European distributor buys product for its inventory upon shipment by the company. In the U.S., a higher average selling price of Oxyglobin during the second fiscal quarter of 2008 offset lower unit sales com
'/>"/>

SOURCE Biopure Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Biopure Appoints Dechra Exclusive U.S. Distributor of Oxyglobin
2. Biopure Announces Date to Meet with UKs Medicines and Healthcare Products Agency
3. Biopure Operations Compliant With U.K. Manufacturing Guidelines
4. Biopure Appoints New Independent Auditor
5. Biopure Completes U.K. Regulatory Agency Inspection
6. Biopure Announces 2008 First Quarter Financial Results
7. Biopure Launches Updated Website
8. Biopure Announces Pricing of Equity Offering
9. Biopure Gives Update on Malaysia Joint Venture Discussions
10. NeoStem Announces Private Placement Financing to Advance Marketing Campaign; Financing Includes Investment from New England Cryogenic Center
11. Rentschler Biotechnologie Announces Cooperation with Boehringer Ingelheim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2015)... FRANCISCO, Calif. , May 20, 2015 /PRNewswire/ ... ) today presented preliminary data demonstrating the ability ... idiopathic pulmonary fibrosis (IPF) from other interstitial lung ... findings suggest the classifier,s potential to help thousands ... to resolve ambiguity in IPF diagnosis – a ...
(Date:5/20/2015)... 19, 2015 Research and Markets ( ... "Global Cell Therapy Market Outlook 2020 " report ... in tissue and regenerative medicine is expected to have ... which could help in the growth of deregulated organs. ... they are unable to form new tissue or sometimes ...
(Date:5/20/2015)... 2015  Health eCareers, the healthcare industry,s online ... job seekers looking for the flexibility of short-term ... and online tool dedicated exclusively to temporary and ... SHIFT enables employers to quickly find and hire ... diem and other temporary positions, eliminating the time ...
(Date:5/20/2015)...  Haemonetics Corporation (NYSE: HAE ) announced today ... present at The Jefferies 2015 Global Healthcare Conference in ... st , 2015 at 8:30am Eastern time.  ... via webcast at: http://wsw.com/webcast/jeff88/hae ... is a global healthcare company dedicated to providing innovative ...
Breaking Biology Technology:Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 3
... PARS ) today reported results for the first quarter ended ... million, or $0.14 per share,for the first quarter 2008 compared ... in the first quarter 2007. Cash and short-term investments,totaled $11.3 ... loss for the first quarter 2008 is due primarily to,a ...
... IRVINE, Calif., May 8 Edwards Lifesciences,Corporation (NYSE: ... heart valves,announced that the company will celebrate a number ... annual meeting of the American,Association for Thoracic Surgery (AATS), ... marked by Edwards -- which this year celebrates,its 50th ...
... Additional Investors ... Next Growth Phase, SAN DIEGO, May 8 CardioDynamics (Nasdaq:,CDIC), ... the reverse split of 1 for 7 shares of the,Company,s common ... earlier today., The record date for the reverse split has ...
Cached Biology Technology:Pharmos Corporation Reports 2008 First Quarter Results 2Pharmos Corporation Reports 2008 First Quarter Results 3Pharmos Corporation Reports 2008 First Quarter Results 4Edwards Lifesciences Celebrates One Million Heart Valve Patients and More at AATS 2008 2Edwards Lifesciences Celebrates One Million Heart Valve Patients and More at AATS 2008 3Edwards Lifesciences Celebrates One Million Heart Valve Patients and More at AATS 2008 4CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Company's Common Stock and Trading in Post-split Shares Begins May 9, 2008 2CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Company's Common Stock and Trading in Post-split Shares Begins May 9, 2008 3
(Date:5/18/2015)... -- Fingerprint Cards (FPC) has received an order ... FPC1035 from one if its module partners. Deliveries are planned ... and the sensors will be used by smartphone manufacturers in ... hereby amount to 740 MSEK to date. In addition to ... a number of smaller orders not separately communicated amounting to ...
(Date:5/14/2015)... 14, 2015  Verificient Technologies, Inc., a ... online remote proctoring, announced a new alliance ... and creator of the Canvas Learning Management ... companies will benefit from the seamless integration ... As a fully integrated multifactor biometrics behavioral ...
(Date:5/11/2015)... May 11, 2015  Through a well-rounded UAS delegation representing ... had a strong showing at AUVSI,s Unmanned 2015 conference last ... Ohio,s UAS industry met with over ... all points along the UAS ecosystem. "Our ... Vice President for Aerospace Rich Knoll . "If you ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2
... which could alleviate the suffering of millions of people with ... clinical testing in patients. Developed and patented by ... with FV-100 has recently been initiated in America. Previous ... times more potent than existing treatments in early lab tests. ...
... of Duchenne Muscular Dystrophy (DMD) for 2 years ... the same length of delay children have endured for ... and treatment. A simple and inexpensive blood test for ... and abnormalities could speed up the process while pilot ...
... (LSTM) has been awarded a 1.1m grant by the ... year project to develop a Field Applicable Screening Tool ... in mosquitoes. The two principal methods for control ... insecticide-treated bednets (ITNs) and indoor residual spraying (IRS) of ...
Cached Biology News:Clinical trials for shingles drug take an important step forward 2Muscular dystrophy diagnosis delayed almost 2.5 years in boys 2$1.6 million grant to lead development of resistance-detecting field kit 2
Moue Serum 8-12 Weeks Old...
... is collected off the clot fasted non-Swiss Albino mice ... Available Anticoagulants: N-02: Citrate N-04: ... Potassium Oxalate N-10: EDTA (Na) ... CPD N-09: K3EDTA N-11: ...
Contains 100 positive controls for effective screening of HDAC inhibitors by fluorometric method....
dynactin 4, mRNA (cDNA clone MGC:3248 IMAGE:3505855), complete cds...
Biology Products: